Vion (formerly Oncorx) interesting play on Gene Therapy Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Oravetz who wrote (208)	9/26/2000 11:39:57 PM
From: Jim Oravetz	Read Replies (1) of 370

NEW HAVEN, Conn. (Dow Jones)--Vion Pharmaceuticals Inc. (VION, news, msgs) said a preclinical study showed that its tumor amplified protein expression therapy, or TAPET, bacterial vector technology enhances imaging of solid tumors. In a press release Tuesday, Vion said the initial tissue imaging studies in experimental tumor-bearing animals have been encouraging. The studies suggest a correlation between the intensity in the images and the number of TAPET bacteria accumulated in different tissues. The images showed high bacterial counts in tumor tissue and relatively low counts in other organs of the body. Vion and the cancer center are planning more experiments to confirm the initial observations. Shares of Vion Pharmaceuticals recently at $13.94, up $1.63, or 13.2%. Nasdaq volume reached 202,400 shares, compared to a daily average of 267,420.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next